Bektaş, E. Et Al. 2022. REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS. AASLD Liver Meeting , (District Of Columbia, United States Of America), 299.

Bektaş, E., Yılmaz, A., Kıkılı, C. İ., Nurıyev, K., İstemihan, Z., Şenkal, İ. V., ... Çavuş, B.(2022). REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS . AASLD Liver Meeting (pp.299). District Of Columbia, United States Of America

Bektaş, Erdem Et Al. "REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS," AASLD Liver Meeting , District Of Columbia, United States Of America, 2022

Bektaş, Erdem Et Al. "REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS." AASLD Liver Meeting , District Of Columbia, United States Of America, pp.299, 2022

Bektaş, E. Et Al. (2022) . "REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS." AASLD Liver Meeting , District Of Columbia, United States Of America, p.299.

@conferencepaper{conferencepaper, author={Erdem BEKTAŞ Et Al. }, title={REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS}, congress name={AASLD Liver Meeting }, city={District Of Columbia}, country={United States Of America}, year={2022}, pages={299} }